Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes

Novo Nordisk A/S0 sites114 target enrollmentSeptember 2007

ConditionsDiabetes Diabetes Mellitus, Type 2

Interventionsinsulin

Drugsinsulin

Overview

Phase: Not Applicable
Intervention: insulin
Conditions: Diabetes
Sponsor: Novo Nordisk A/S
Enrollment: 114
Primary Endpoint: Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Similar Trials

Overview

Brief Summary

This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.

Registry

clinicaltrials.gov

Start Date

September 2007

End Date

March 2009

Last Updated

2 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Novo Nordisk A/S

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Type 2 diabetes patients
•Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
•HbA1c greater than or equal to 8.0%